insights_auto
Why is PLUR down 8.58%?
Dive Deeperchevron_right
PLUR:NASDAQ
Pluri Inc
$0.85
arrow_downward
-8.58%(-0.080) 1D
Oct 19, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PLUR...
Open
$0.90
High
$0.96
Low
$0.85
Mkt. cap
10.49M
Avg. vol.
15.85K
Volume
8.04K
52-wk high
$4.86
52-wk low
$0.85
EPS
-$2.44
Beta
0.69
Shares outstanding
12.61M
No. of employees
103
Open
$0.90
High
$0.96
Low
$0.85
Mkt. cap
10.49M
Avg. vol.
15.85K
Volume
8.04K
52-wk high
$4.86
52-wk low
$0.85
EPS
-$2.44
Beta
0.69
Shares outstanding
12.61M
No. of employees
103
News stories
From web sources and news partners
Stocktwits
·
32 minutes ago
Dow, S&P 500, Nasdaq Edge Higher Amid Tech Rebound As Q3 Earnings Season Forges Ahead: DJT, AMZN, CBRS, CRWV Stocks In Focus
Yahoo Finance
·
51 minutes ago
Sam Stovall says history is key to what happens to the S&P 500 next year
Crypto Briefing
·
6 hours ago
AI stocks now make up 49% of the S&P 500, the second-highest concentration on record
Profile
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas. Wikipedia
About Pluri Inc
CEOYaky Yanay
Employees103
FoundedMay 11, 2001
HeadquartersHaifa, Haifa District, Israel
SectorBiotechnology
Websitepluri-biotech.com